1 results match your criteria: "7 Vanderbilt-Ingram Cancer Center[Affiliation]"
The Attenuation Distribution Across the Long Axis of Breast Cancer Liver Metastases at CT: A Quantitative Biomarker for Predicting Overall Survival.
AJR Am J Roentgenol
January 2018
7 Vanderbilt-Ingram Cancer Center, Nashville, TN.
Objective: The objective of our study was to compare attenuation distribution across the long-axis (ADLA) measurements, Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1, and Choi criteria for predicting overall survival (OS) in patients with metastatic breast cancer treated with bevacizumab.
Materials And Methods: We obtained HIPAA-compliant data from a prospective, multisite, phase 3 trial of bevacizumab for the treatment of metastatic breast cancer.